Huntsworth (HNT) Share Price, News & Analysis

Company Overview

Huntsworth plc, together with its subsidiaries, operates as a healthcare and communications company in the United Kingdom and rest of Europe, the United States, and internationally. The company operates through four divisions: Medical, Marketing, Immersive, and Communications. The Medical division provides scientific strategy and communications, publications planning and delivery, specialized medical writing, medical education, and payer and value communications services, as well as support services for internal medical teams. This division serves pharmaceutical and biotechnology clients. The Marketing division markets prescription drugs to consumers and healthcare professionals; and provides healthcare public relations agency and payer marketing services. This segment serves biotech and pharma, OTC, wellness, and lifestyle brands. The Immersive division creates and delivers live experiences, and scientific and interactive contents; creates and produces various films, including short and internal engagement films, documentaries, and action demonstrations; develops immersive experiences for employees training and explaining complex science; and designs strategic and creative programs to engage internal audiences. This division primarily serves healthcare industry. The Communications division provides public relations and affairs, and investor relations solutions; and communication consulting services primarily for cross-border financial transactions and multinationals to broaden their global footprint, as well as develops and manages campaigns, runs press offices, and steers brands and businesses through engagement with media, consumers, customer stakeholders, and internal audiences. The company was formerly known as Holmes & Marchant Group plc and changed its name to Huntsworth plc in July 1999. Huntsworth plc was incorporated in 1983 and is headquartered in London, the United Kingdom.

Key Stats

• Today's Range: 107.50 to 107.52
• 50-Day Range: 107.50 to 107.50
• 52-Week Range: 58.24 to 111
• Volume: 505,026 shs
• Average Volume: 5.46 million shs
• Market Capitalization: £399.60 million
• P/E Ratio: 19.91
• Dividend Yield: 2.79%
• Price Target: N/A
• Consensus Rating: N/A

HNT Stock Analysis - Frequently Asked Questions

How have HNT shares performed this year?

Huntsworth's stock was trading at GBX 107.50 at the start of the year. Since then, HNT stock has increased by 0.0% and is now trading at GBX 107.50.
View the best growth stocks for 2024 here.

How were Huntsworth's earnings last quarter?

Huntsworth plc (LON:HNT) issued its earnings results on Tuesday, July, 24th. The company reported $2.60 EPS for the quarter, missing the consensus estimate of $2.80 by $0.20.

How do I buy shares of Huntsworth?

Shares of HNT stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of Huntsworth own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Huntsworth investors own include Derwent London (DLN), Oracle (ORCL), Global Ship Lease (GSL), IP Group (IPO), Legal & General Group (LGEN), London Stock Exchange Group plc (LSE.L) (LSE) and Petrofac (PFC).

Company Calendar

• Last Earnings: 7/24/2018
• Today: 11/04/2024

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Business Services
• Industry: Advertising Agencies
• Sub-Industry: N/A
• Current Symbol: LON:HNT
• CUSIP: N/A
• CIK: N/A
• Web: www.huntsworth.com
• Phone: +44-20-72248778
• Fax: N/A
• Employees: 1,903
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: 19.91
• Forward P/E Ratio: 0.24
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: 64.36
• Current Ratio: 1.19
• Quick Ratio: 1.07

Sales & Book Value

• Annual Sales: £264.85 million
• Price / Sales: 1.51
• Cash Flow: GBX 6.10 per share
• Price / Cash Flow: 17.62
• Book Value: GBX 49.80 per share
• Price / Book: 2.16

Miscellaneous

• Outstanding Shares: 371,718,016
• Free Float: N/A
• Market Cap: £399.60 million
• Optionable: Not Optionable
• Beta: N/A